Concepedia
Statistics
Publications
27
Citations
1.4K
H-Index
22
Active since
1993
Affiliations
Novartis (Switzerland)(Current)
The Ohio State University
Pfizer (United States)
Novartis (United States)
Duke Medical Center
William R. Tschantz is an author at Novartis (Switzerland) specializing in life sciences, enzymology, and biochemistry.
Publications per year
1993–2024
TEM8/ANTXR1 Blockade Inhibits Pathological Angiogenesis and Potentiates Tumoricidal Responses against Multiple Cancer Types
Amit Chaudhary, Mary Beth Hilton, Steven Seaman et al. · Cancer Cell · 2012 · 160 citations · Full text
Medicine, Oncology, Pharmacology +12
A serine and a lysine residue implicated in the catalytic mechanism of the Escherichia coli leader peptidase.
William R. Tschantz, Meesook Sung, Vondolee Marie Delgado-Partin et al. · Journal of Biological Chemistry · 1993 · 123 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +17
Interaction with both ZNRF3 and LGR4 is required for the signalling activity of R‐spondin
Yang Xie, Raffaella Zamponi, Olga Charlat et al. · EMBO Reports · 2013 · 110 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +4
Substrate Binding Is Required for Release of Product from Mammalian Protein Farnesyltransferase
William R. Tschantz, Eric S. Furfine, Patrick J. Casey · Journal of Biological Chemistry · 1997 · 98 citations · Full text
Use of Site-directed Chemical Modification to Study an Essential Lysine in Escherichia coli Leader Peptidase
Mark Paetzel, N.C.J. Strynadka, William R. Tschantz et al. · Journal of Biological Chemistry · 1997 · 77 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +16
1–5 of 27